TANGO. Efficacy and safety of switching to Dolutegravir/Lamivudine Fixed-Dose 2-Drug Regimen vs continuing a Tenofovir Alafenamide-Based 3- or 4-Drug Regimen for maintenance of virologic suppression in adults living with Human Immunodeficiency Virus Type 1: phase 3, randomized, noninferiority TANGO Study.
van Wyk J., Ajana F., Bisshop F., De Wit S., Osiyemi O., Portilla Sogorb J., Routy J-P., Wyen C., Ait-Khaled M., Nascimento MC., Pappa KA., Wang R., Wright J.,Tenorio AR., Wynne B., Aboud M., Gartland MJ., Smith KY. Clin Infect Dis 2020;71(8):1920-1929. doi: 10.1093/cid/ciz1243.